Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
05/2003
05/30/2003WO2003043657A1 Topical delivery of codrugs
05/30/2003WO2003043647A2 A plant extract active as an immunostimulating agent
05/30/2003WO2003043638A1 Coated particulate cefuroxime axetil compositions
05/30/2003WO2003043628A1 Medicament for the treatment of viral skin and tumour diseases
05/30/2003WO2003043623A1 Antiviral, antibacterial pharmaceutical composition of cantharidic anhydride and method of preparation thereof
05/30/2003WO2003043613A2 Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents
05/30/2003WO2003043587A2 Recovery of recombinant human parainfluenza virus type 1 (hpiv1) from cdna
05/30/2003WO2003043583A2 Treatment of immunological disorders using anti-cd30 antibodies
05/30/2003WO2003043580A2 Methods for identifying and validating potential drug targets
05/30/2003WO2003043574A2 Pharmaceutical compositions in particulate form
05/30/2003WO2003043572A2 Methods and compositions related to irm compounds and toll-like receptor pathways
05/30/2003WO2003043518A2 Methods and products for oral care
05/30/2003WO2003043418A1 Anti-pathogenic composition useful in blood preservation
05/30/2003WO2003026691A3 Use of hmgb1 for the activation of dendritic cells
05/30/2003WO2003025176A3 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
05/30/2003WO2003010141A3 Hepatitis c virus polymerase inhibitors with a heterobicyclic structure
05/30/2003WO2003007870A3 Oxazolidinone derivatives as antimicrobials
05/30/2003WO2003005952A3 Compositions and methods for delivery of proteins and adjuvants encapsulated in microspheres
05/30/2003WO2003004650A3 Group b streptococcus antigens and corresponding dna fragments
05/30/2003WO2002100890A3 Respiratory syncytial virus
05/30/2003WO2002100328A3 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels
05/30/2003WO2002096952A3 Conjugate of a transport protein and a protein for modulation of notch signalling
05/30/2003WO2002095029A3 Nucleic acid and protein sequences of bovine epidermal growth factor
05/30/2003WO2002085848A8 Synthesis of pancratistatin prodrugs
05/30/2003WO2002078718A3 Compositions, methods and apparatuses for singlet oxygen delivery
05/30/2003WO2002078698A3 Polarisation of dendritic cells (treatment of infections, cancer and autoimmune diseases) using histamine
05/30/2003WO2002076485A3 Vaccine for modulating between t1 and t2 immune responses
05/30/2003WO2002072621A3 Cyclohexapeptide having antimicrobial activity
05/30/2003WO2002058624A3 In situ generation allicin for the treatment of cancer and infectious diseases
05/30/2003WO2002057314A3 Prevention and treatment of hcv infection employing antibodies directed against conformational epitopes
05/30/2003WO2002055490A3 Metabolic controlled fermentation process for carbamoyl tobramycin production
05/30/2003WO2002053728A9 Gene disruption methodologies for drug target discovery
05/30/2003WO2002036160A3 Method for obtaining antigenic structures enhancing specific cross reactivity
05/30/2003WO2002031025A9 Biodegradable poly(beta-amino esters) and uses thereof
05/30/2003WO2002000692A9 Pd-l2 molecules: pd-1 ligands and uses therefor
05/30/2003WO2001096381A3 IMMUNIZATION OF DAIRY CATTLE WITH GapC PROTEIN AGAINST STREPTOCOCCUS INFECTION
05/30/2003WO2001080823A3 Composition exhibiting enhanced formulation stability and delivery of tropical active ingredients
05/30/2003WO2001052874A9 Intra-tumoral administration of il-12 encoding nucleic acid molecules
05/30/2003CA2468107A1 Methods for identifying and validating potential drug targets
05/30/2003CA2467958A1 Recovery of recombinant human parainfluenza virus type 1 (hpivi) from cdna
05/30/2003CA2467930A1 Treatment of pml targeting jc virus agno
05/30/2003CA2467927A1 Antimicrobial polypeptides from pseudoplectania nigrella
05/30/2003CA2467856A1 Anti-pathogenic composition useful in blood preservation
05/30/2003CA2467752A1 Piperidin-2-one derivative compounds and pharmaceutical composition comprising the same as active ingredient
05/30/2003CA2467747A1 Methods and products for oral care
05/30/2003CA2467559A1 Topical delivery of codrugs
05/30/2003CA2467242A1 Treatment of immunological disorders using anti-cd30 antibodies
05/30/2003CA2467206A1 Genes encoding g-protein coupled receptors and methods of use therefor
05/30/2003CA2467104A1 A plant extract active as an immunostimulating agent
05/30/2003CA2467053A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
05/30/2003CA2466982A1 Pharmaceutical compositions in particulate form
05/30/2003CA2466937A1 Methylated heparin-binding hemagglutinin (hbha) recombinant mycobacterial antigen
05/30/2003CA2466733A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/30/2003CA2466491A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/30/2003CA2466072A1 Substituted indolizine-like compounds and methods of use
05/29/2003US20030100764 Thioether substituted imidazoquinolines
05/29/2003US20030100759 Selective anti-viral nucleoside chain terminators
05/29/2003US20030100755 For example (2S, 3S, 5S)-2-(2,6-dimethylphenoxyacetyl)amino-3-hydroxy-5-(2S-(1-tetrahydro-pyrimid-2-onyl)-3-methyl butanoyl)amino-1,6-diphenylhexane; HIV therapy
05/29/2003US20030100751 Coupling condensation synthesis of heterocycles
05/29/2003US20030100742 Erythromycin a derivatives
05/29/2003US20030100614 Use of thiamphenicol and derivatives thereof for the preparation of pharmaceutical compositions useful in the treatment of chlamydia pneumoniae infections
05/29/2003US20030100607 Thiolalkyl benzoic acid derivatives
05/29/2003US20030100603 Administering to the patient subject to a C-reactive protein associated inflammatory condition, an effective amount of a non-alpha-tocopherol enriched tocopherol
05/29/2003US20030100588 Indole-type inhibitors of p38 kinase
05/29/2003US20030100563 Such as 7-((3R)-3-amino-4-(3,4-difluorophenyl)butanoyl)-2-(trifluoromethyl)-5,6,7,8 -tetrahydroimidazo(1,2-a)pyrazine dihydrochloride for treatment of insulin resistance disorders
05/29/2003US20030100537 Calcium (3S) tetrahydro-3-furanyl (1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-(phos-phonooxy)propylcarbamate
05/29/2003US20030100536 Treating a herpes virus, atherosclerosis or restenosis
05/29/2003US20030100521 For therapy of HIV infection
05/29/2003US20030100518 13-Methyl erythromycin derivatives
05/29/2003US20030100517 For therapy of diseases involving fungal or suspected fungal infection, for immunomodulation or immunosuppression in conditions in which fungal or suspected fungal colonisation of e.g.skin plays a role
05/29/2003US20030100510 Crystallized structure of type IV collagen NC1 domain hexamer
05/29/2003US20030100115 Killing cells that lack tumor suppressor proteins; obtain cells, transform with preferential single stranded nucleotide sequence, monitor viability of cells
05/29/2003US20030100083 Preparation of pseudomonic acid A; obtain bacteria capable of producing pseudomonic acid A, culture, ferment and isolate pseudomonic acid A from culture
05/29/2003US20030100071 Polypeptide for use in the prevention and treatment of bacterial infections
05/29/2003US20030100017 Prevention of microorganismal infections; obtain sample of microorganism, incubate with tetracycline compound, monitor propagation of microorganism, reduced propagation indicates effective fungicide
05/29/2003US20030099959 Cooperative oligonucleotides
05/29/2003US20030099955 Detection of enzyme modulators; obtain three dimensional structure of enzyme, design modulator to bind active site, incubate with test modulator, monitor adjustment in enzyme activity
05/29/2003US20030099934 Envelope protein for use in the treatment and prevention of viral diseases
05/29/2003US20030099765 Process for coating a surface of a stent
05/29/2003US20030099747 Thickened oil compositions of edible oil
05/29/2003US20030099730 Nutritional supplement and methods of using it
05/29/2003US20030099726 Medicine comprises Echinacea phytochemicals and benzalkonium chloride in a sterile water solution; for therapy
05/29/2003US20030099725 For therapy and prophylaxis of cancers especially cancer of lung, esophagus, stomach, oral cavity and prostate as well as for therapy of Helicobacter pylori infection; useful as adjuncts to conventional surgery or radiotherapy
05/29/2003US20030099718 Nanocrystalline antimicrobial metals (noble metals)formed with atomic disorder are capable of releasing highly active clusters of the antimicrobial metal sufficient to cause microbiocidal effect; anti-inflammatory activity
05/29/2003US20030099694 Method for the improvement of transport across adaptable semi-permeable barriers
05/29/2003US20030099673 Use of such polypeptides and nucleic acids encoding them as vaccines and diagnostic reagents
05/29/2003US20030099672 N Streptococcus pneumoniae polysaccharides conjugated to tetanus toxoid and p Streptococcus pneumoniae polysaccharides conjugated to diphtheria toxoid for vaccine which protects against Clostridium tetani and/or Corynebacterium diphtheriae
05/29/2003US20030099671 Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS
05/29/2003US20030099668 Comprises loading (transfection) immunogenic DNA oligonucleotides for enhanced lymphocyte response; genetic engineering
05/29/2003US20030099667 Virus modified by the insertion of cDNA of serotypes
05/29/2003US20030099656 Monoclonal antibodies to the ClfA protein and method of use in treating or preventing infections
05/29/2003US20030099654 Comprises antibodies/proteins providing inhibition of prothrombinase; treatment and prevention of bacterial and viral infections, allograft/xenograft rejection, glomerulo-nephritis, cancer, gastrointestinal diseases, and fetal loss
05/29/2003US20030099621 Screening cells to identify stem cells having a beneficial gene, and transplanting the cells into a patient to treat HIV or AIDS
05/29/2003US20030099613 An encoded repressor or activator and a viral nucleotide sequence for replication; preparing a vaccine for the prophylaxis of AIDS, human immunodeficiency virus
05/29/2003US20030099608 Human cytokine receptor
05/29/2003US20030099606 Iodinating an strong base anion exchange resin with iodine or an iodine compound; abosorbing through the pores of ion exchange resin
05/28/2003EP1314732A2 Substituted pyrimidine compounds and their use
05/28/2003EP1314731A2 Substituted pyrimidine compounds and their use
05/28/2003EP1314728A1 Pyridyl and pyrimidinyl imines as intermediates for imidazole derivatives
05/28/2003EP1314726A1 Novel ester or amide derivatives
1 ... 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 ... 1798